Innovation Center of Advanced Therapies (ICAT)
Innovation Center of Advanced Therapies (ICAT)
What is ICAT? uitklapper, klik om te openen
ICAT aims to improve and accelerate the translation of research into healthcare solutions by bringing together all relevant expertise and infrastructure for the development of regenerative treatments, Advanced Therapy Medicinal Products (ATMPs) including cell therapy, and disease models.
In deze folder bevindt zich extra informatie door middel van een video. Scan de bovenste QR-code met uw telefoon om deze video te bekijken. Of bekijk de video via:
ICAT is an innovation space that holds the possibility to develop new health care solutions and test regenerative treatments on a larger scale. It provides the opportunity to simulate, refine, and standardize manufacturing processes and develop new health care solutions.
ICAT builds bridges between research and clinical practice, by uniting all relevant expertise and infrastructure to optimize patient-specific advanced therapies.
ICAT supports clinicians, academic institutions and small, medium, and large commercial organizations worldwide.
Facilities uitklapper, klik om te openen
ICAT integrates 3 facilities
ICAT offers
- (Technical) feasibility studies and (co-)development.
- Develop, validate and implement GMP-compliant production protocols and QC methods.
- Small scale and personalized GMP production.
- Training, consultancy and coaching on the go-to-market.
Utrecht Science Park uitklapper, klik om te openen
Utrecht Science Park (USP) is located in the center of the Netherlands and home to excellent knowledge institutes and start-ups. In addition to the presence of the UMC Utrecht and the Prinses Máxima Center for Pediatric Oncology, it enables clinical testing and implementation. Its researchers are continuously working on cutting edge technologies and therapies.
News uitklapper, klik om te openen
Mimics Innovation Awards Winner: Nasim Golafshan
Read more
RegMedXB Pilotfabriek opened its doors for the National Growth Fund committee
Read more
Regmed XB and DCVA valorisation community event: Scaling and Manufactoring
Read more
Recommended read: (Bio)fabrication of microfluidic devices and organs-on-a-chip
Read more
International Conference on Biofabrication 2022
Read more
33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine
Read more